Company intelligence / Profile preview

Cardiologix

Irvine, California, USA

Ownership: Private
Development stage: Other

Overview

CardioLogix was a medical technology company specializing in the development of percutaneous heart valve repair technologies. The company's primary focus was on creating minimally invasive solutions for mitral regurgitation, a condition where the heart's mitral valve does not close tightly. Its lead technology was a catheter-based system designed to repair the mitral valve without requiring invasive open-heart surgery. In May 2007, CardioLogix was acquired by Edwards Lifesciences for approximately 27 million in cash plus potential milestone payments. This acquisition bolstered Edwards Lifesciences' leadership in the structural heart disease market and expanded its transcatheter therapy pipeline.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Cardiologix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiologix.

Explore the full profile